Results 31 to 40 of about 81 (74)

[High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Yang M, Zhu X, Shen Y, He Q, Qin Y, Shao Y, Yuan L, Ye H.   +7 more
europepmc   +1 more source

[Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and preoperative/postoperative membranous urethral length]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2022
Zhang F, Chen Q, Hao YC, Yan Y, Liu C, Huang Y, Ma LL.   +6 more
europepmc   +1 more source

[⁶⁸Ga-PSMA-I&T PET/CT for assessment of tumor burden in primary lesions of treatmentnaïve prostate cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Xie Y, Li C, Zhang L, Zang S, Yu F, Wang S, Wang F.   +6 more
europepmc   +1 more source

[Relationship between prostate apex depth and early recovery of urinary continence after laparoscopic radical prostatectomy]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2021
Zhang F, Huang XJ, Yang B, Yan Y, Liu C, Zhang SD, Huang Y, Ma LL.   +7 more
europepmc   +1 more source

[Research status and prospect of artificial intelligence technology in the diagnosis of urinary system tumors]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2021
Liu K, Zhang M, Li H, Wang X, Li D, Liu S, Yang K, Sun Z, Xue L, Cui Z.   +9 more
europepmc   +1 more source

Progress in diagnosis of bone metastasis of prostate cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Liu J, Dong Y, Xu D, Zhang C, Lan T, Chang D.   +5 more
europepmc   +1 more source

Clinical application and progress of quantitative functional magnetic resonance imaging in prostate cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Li M, Li W.
europepmc   +1 more source

[Evaluating continence recovery time after robot-assisted radical prostatectomy]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2021
Hao H, Liu Y, Chen YK, Si LM, Zhang M, Fan Y, Zhang ZY, Tang Q, Zhang L, Wu SL, Song Y, Lin J, Zhao Z, Shen C, Yu W, Han WK.   +15 more
europepmc   +1 more source

[Clinical efficacy of docetaxel combined with carboplatin in patients with metastatic castration-resistant prostate cancer]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2021
Bai GC, Song Y, Jin J, Yu W, He ZS.
europepmc   +1 more source

[Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Yang X, Zhang F, Ma L, Liu C.
europepmc   +1 more source